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ABSTRACT
The absence of a quality control (QC) system is a
major weakness for the comparative analysis of
genome-wide profiles generated by next-generation
sequencing (NGS). This concerns particularly
genome binding/occupancy profiling assays like
chromatin immunoprecipitation (ChIP-seq) but also
related enrichment-based studies like methylated
DNA immunoprecipitation/methylated DNA binding
domain sequencing, global run on sequencing or
RNA-seq. Importantly, QC assessment may signifi-
cantly improve multidimensional comparisons that
have great promise for extracting information from
combinatorial analyses of the global profiles estab-
lished for chromatin modifications, the bindings
of epigenetic and chromatin-modifying enzymes/
machineries, RNA polymerases and transcription
factors and total, nascent or ribosome-bound
RNAs. Here we present an approach that associates
global and local QC indicators to ChIP-seq data sets
as well as to a variety of enrichment-based studies
by NGS. This QC system was used to certify >5600
publicly available data sets, hosted in a database for
data mining and comparative QC analyses.
INTRODUCTION
The recent development of high-throughput sequencing
technologies has led to a rapid expansion of studies
analyzing the genome-wide patterns of gene regulatory
events and features, such as epigenetic DNA and histone
modiﬁcation, and the binding patterns of transcription
factors and their co-regulatory complexes, (posttransla-
tionally) modiﬁed chromatin-associated factors and
chromatin- or transcription-modulatory multi-subunit
machineries (1–9). Moreover, the mapping of transcrip-
tomes by RNA-seq (10–13), global nascent RNA
sequencing or global run on sequencing (GRO-seq) (14)
or ribosome-associated (‘ribosome footprinting’) RNAs
(15), and technologies revealing chromatin conformation
are also based on massive parallel sequencing (16–18).
A particular challenge is the comparison of multidimen-
sional proﬁles for several factors, their posttranslational
modiﬁcations and/or chromatin marks. Indeed, such
studies are not easily comparable, as they are performed
in different settings by different individuals using differ-
ent cells and antibodies. Moreover, proﬁles are estab-
lished at different platforms with highly variable
sequencing depths. As a result, studies performed even
with the same cells in different laboratories can differ
extensively (3). This presents serious limitations for the
interpretation of such global comparative studies and
reveals the need for a quantiﬁable system for assessing
the quality and comparability of next-generation
sequencing (NGS)-derived proﬁles and moreover the ro-
bustness of local features, such as peaks at particular loci,
which are derived from the mapping of read-count
intensities (RCIs).
A large number of factors can inﬂuence the quality
of NGS-based proﬁlings. Particularly in the case of
immunoprecipitation-based approaches [e.g. chromatin
immunoprecipitation (ChIP-seq), methylated DNA
immunoprecipitation (19,20), GRO-seq (21)], experimental
parameters like cross-linking efﬁciencies in different cell
types or tissues, shearing or digestion of chromatin or the
selectivity and afﬁnity of an antibody (batch) can vary sub-
stantially between experiments and different experimenters
and will ultimately impact on the overall quality of the ﬁnal
readout. Currently, quality assessment is performed by
visual proﬁle inspection of deﬁned chromatin regions and
complemented by peak caller predictions. In addition, a
number of analytical methods have been described [for
a recent summary of the methodologies used by the
ENCODE consortium see (22)]. However, none of them
has been shown to be applicable to the large variety of
ChIP-seq and enrichment-related NGS proﬁling assays.
For instance, methods like fraction of mapped reads
*To whom correspondence should be addressed. Tel: +33 3 88 65 34 73; Fax: +33 3 88 65 34 37; Email: hg@igbmc.u-strasbg.fr
Correspondence may also be addressed to Marco-Antonio Mendoza-Parra. Tel:+33 3 88 65 34 19; Fax:+33 3 88 65 34 37; Email: marco@igbmc.fr
Published online 14 September 2013 Nucleic Acids Research, 2013, Vol. 41, No. 21 e196
doi:10.1093/nar/gkt829
 The Author(s) 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial
re-use, please contact journals.permissions@oup.com
Downloaded from https://academic.oup.com/nar/article-abstract/41/21/e196/1280676
by UNIVERSITE LOUIS PASTEUR SERVICE COMMUN DE DOCUMENTATION user
on 06 February 2018
retrieved into peak regions (FRiP) (23) or irreproducibility
discovery rate (IDR) (24) require prior use of peak calling
algorithms for evaluation and are therefore dependent on
peak-calling performance of a given tool with the user-
deﬁned parameters. Consequently, they cannot be easily
used for multi-proﬁle comparisons when different peak
callers are required (e.g. transcription factors (TFs) and
histone modiﬁcations with ‘broad’ proﬁles).
In addition to the performance of the immunopre-
cipitation/enrichment assays, the rapid technological
progress provided NGS platforms with largely different
sequencing capacities ranging from tens of millions (e.g.
Illumina Genome analyzer v1, hereafter referred to as
‘GA1’) to >3 billion (HiSeq2000) reads per ﬂow cell.
As a consequence, the public databases hosting NGS-
generated data sets are populated with ChIP-seq proﬁles
presenting a large variety in sequencing depth.
Importantly, previous studies have demonstrated that by
increasing the sequencing depth, the number of discovered
binding sites increases accordingly. Intuitively, it is
expected that the number of sequenced reads required to
discover all binding events is directly related to their total
number and to their binding pattern (i.e. ‘broad’ regions
covering large parts of a genome will require more reads
to be properly identiﬁed than ‘sharp’ patterns with few
target sites). When evaluating the quality of NGS-based
proﬁling, it is therefore important to assess if a given
ChIP-seq proﬁle is performed under optimal sequencing
conditions, including the minimal sequencing depth
required to discover most of the relevant binding events
of a given factor.
For all the above reasons, we have developed a bio-
informatics-based quality control (QC) system that uses
raw NGS data sets to (i) infer a set of global QC indicators
(QCis), which reveal the comparability of different
enriched-NGS data sets, (ii) provide local QCis to judge
the robustness of cumulative read counts (‘peaks or
islands’) in a particular region, (iii) provide guidelines
for the choice of the optimal sequencing depth for a
given target and, ﬁnally, (iv) to have quantitative means
of comparing different antibodies and antibody batches
for ChIP-seq and related antibody-driven studies. In
addition, we have established a QC indicator database
that will be expanded to cover virtually all publicly avail-
able enrichment-related NGS proﬁling assays. Thus, users
can compare the quality indicators computed by the
NGS-QCi Generator for a given ChIP-seq experiment
with the quality indicators for published data sets
present in the QC indicator database. This information
will guide users toward optimization of the ChIP-seq
process, if the QC is lower than that achieved previously
by others and/or with other antibodies. Moreover, this QC
system will be useful for antibody development and certi-
ﬁcation. We discuss the simplicity and versatility of the
present QC method and database in view of currently
existing QC assessment procedures and guidelines. The
NGS-QC Database of QC indicators for publicly available
proﬁles and the NGS-QC Generator tool are freely
accessible through a customized Galaxy instance at
http://igbmc.fr/Gronemeyer_NGS_QC.
MATERIALS AND METHODS
Data sets
Publicly available data sets were downloaded from GEO
(25). When available, aligned ﬁles (either in BED or BAM
format) were used; otherwise sequence data sets, available
through the short read archive database, were ﬁrst aligned
to the corresponding reference genome using Bowtie2
under standard alignment options (26).
Assessment of the inherent robustness of ChIP-seq proﬁles
Based on the rationale that beyond a sequencing depth
threshold a ChIP-seq proﬁle changes only in amplitude
but not in pattern, we evaluated this property by monitor-
ing the changes of its RCIs after read-subsampling.
For this, aligned reads were randomly sampled at three
distinct densities (90, 70 and 50%; referred to as s90, s70
and s50 subsets, respectively). To avoid bias, random
sampling was performed without replacement; each separ-
ately sampled density subset was generated from the
original read data set. RCI proﬁles were constructed by
counting the overlaps within a deﬁned window (‘bin’).
With the aim of having no more than one binding event
per bin, it is currently ﬁxed to 500 bp. An empirical evalu-
ation of the inﬂuence of this parameter on the assessment
of the quality indicators conﬁrmed our initial choice
(Supplementary Figure S1d).
Reconstructed proﬁles from randomly sampled subsets
are then compared with that constructed from the initial
total mapped reads (TMRs) by computing the recovered
RCI (recRCI) per bin after sampling as follows:
recRCI ¼ ðsamRCI
oRCI
Þ  100
Where samRCI is the RCI/bin retrieved after sampling
and oRCI is that found in the original proﬁle. Under the
working hypothesis that, as a consequence of random
sampling, recRCI is directly proportional to the
sampling density, the divergence from the expected RCI
behavior is measured as follows:
@RCI ¼ samd recRCI
where samd corresponds to the random sampling density;
i.e. 90, 70 and 50% for s90, s70 and s50, respectively.
Importantly, the RCI dispersion or dRCI is inversely pro-
portional to the original RCI (Supplementary Figure S1C)
and it has been empirically observed to present a direct
correlation with the quality of ChIP-seq proﬁles
(Supplementary Figure S2). Thus, for providing a quanti-
tative assessment of the changes of RCI dispersion in a
given data set, we have evaluated the fraction of bins dis-
playing a dRCI within in a given interval, which has been
deﬁned as the global density QC indicator ‘denQCi’. This
global indicator—evaluated in conditions where only a
half of the initial sequenced reads are available (s50)—is
systematically used in this study to measure the degree
of robustness of the evaluated proﬁle to the read-
subsampling treatment (i.e. high denQCi corresponds to
low RCI dispersion). In addition, the changes in robust-
ness on subsequent read subsampling has been evaluated
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by comparing the denQCi for the sampling closest to the
original proﬁle (s90) with that sampling only half of the
sequenced reads (s50). This is deﬁned as the similarity
QC (simQCi) indicator, computed as ratio between
denQCis for the s90 and s50 sampling subsets. The
current version of NGS-QCi Generator provides both
global quality indicators (denQCi and simQCi) for disper-
sion intervals of 2.5, 5 and 10%. Further details concern-
ing the assessment of these indicators are provided in the
QC report (see Supplementary File S1 and Supplementary
Figure S4).
Local QCis
Given that the above analyses were computed for 500-bp
bins, the dRCI/bin data can be used as local QCis. The
NGS-QCi Generator provides such information in either
wiggle or BED formats; the default condition identiﬁes
bins with dRCI 10%. Local QCis in wiggle ﬁle format
can be uploaded in the Integrated Genome Browser (IGB)
and displayed as a heat-map together with standard RCI
wiggle ﬁles (as illustrated in Figure 3B). In a similar
manner, the corresponding BED ﬁle can be uploaded in
the UCSC Genome Browser. This display option is useful
to visualize predicted dRCIs associated to a given chro-
matin region of interest. Furthermore, 500-bp chromatin
regions with dRCIs thresholds of 2.5, 5 or 10% can be
downloaded as a table in BED format. The data sets fa-
cilitate comparative analyses of multiple proﬁles in the
context of deﬁned dRCI thresholds.
QC-STAMP and NGS-QCi database
The contribution of the two QCis to the single descriptor
QC-STAMP was deﬁned by following equation:
QC-STAMP ¼ denQCiðs50Þ
simQCi
To evaluate the divergence of this global descriptor over
all enrichment-related NGS proﬁles currently compiled in
the NGS-QC database, the QC-STAMP distributions
assessed for three different RCI dispersion intervals were
subdivided in four quantiles to which the following grades
have been attributed: ‘D’, lower quartile (<25%); ‘C’, in-
terquartile 25–50%; ‘B’, interquartile 50–75% and ‘A’
upper quartile (>75%). The NGS-QCi Generator
database associates these grades for 2.5, 5 and 10%
dRCI to each proﬁle as a three-letter symbol, such that,
for example AAA (‘triple A’) reveals an A grade for all
three dRCIs. All available proﬁles are displayed as a
dynamic QC-STAMP versus TMR scatterplot, which
allows judging of their QCi similarities in the context of
the sequencing depth. Note that the global QC-STAMP
descriptor will be dynamically reevaluated when novel
entries are provided to the database.
Peak detection approach
In addition to the well-described peak caller MACS (27),
peak calling has been performed with MeDiChI, a model-
based deconvolution approach originally developed for
ChIP-chip assays (28), which we have adapted to
ChIP-seq analyses. MeDiChI computes a model from a
randomly selected subset of the multiple binding events
present in a genome-wide proﬁle. This model is then
used as a deconvolution kernel for genome-wide predic-
tion of likely binding events, which are further validated
by nonparametric bootstrapping. As we compared ChIP-
seq proﬁles generated at different sequencing depths, we
have included a P-value/peak intensity product ranking-
based approach for deﬁning a common false discovery
rate (FDR) during comparison. For this, a ranking coef-
ﬁcient (RC) for the ith peak identiﬁed by MeDiChI was
calculated by the following equation:
RCi ¼ IntPeak i  ð10  log10ðp valueiÞÞ
This RC was sorted from the highest to the lowest
value, and the FDR was assessed as follows:
FDRi ¼ 10  log10ð
i
N
p valueiÞ
Where i* is the ranking position based on the RC, and N
is the total number of peaks. Thus, all ERa ChIP-seq
proﬁles have been compared at a FDR threshold 45 or
FDR adjusted P-value threshold 104.5.
RESULTS
Previous studies described the concept of a ‘saturation
point’ as the sequencing depth after which no new
binding sites are identiﬁed by a given peak caller with
additional sequenced reads (5,29). This concept has been
initially evaluated in a retrospective manner by assessing
the number of signiﬁcant binding sites retrieved when only
a subset of the original sequenced reads was used for
proﬁle reconstruction (random subsampling approach).
Intuitively the ‘saturation point’ concept predicts that
beyond such threshold no further binding sites would be
discovered and by consequence, the increased sequencing
depth should only inﬂuence the overall read-count inten-
sity of the corresponding proﬁle.
Following the same concept, the QC system presented
here evaluates the stability of the pattern of a given proﬁle
beyond the saturation point by measuring the reproduci-
bility of ChIP-seq and enrichment-related NGS proﬁles
under conditions where only a subset of the TMRs are
used for reconstruction. In the ideal ‘saturation’ condition,
such a reconstruction will generate a proﬁle with the same
read distribution pattern across the genome but with a
decrease of the RCIs according to the percentage of
TMRs used (Figure 1A). The extent to which this reprodu-
cibility is attained is deﬁned as ‘robustness’ of the original
proﬁle and is assessed by the resampling of a given data set
at the level of half of the original TMRs (referred to as
‘s50’). Whereas none of the currently available proﬁles
displays ideal robustness at s50, the evaluation of the de-
viation from such ideal behavior reﬂects the degree of ro-
bustness and represents a quantitative method for
assigning a set of quality descriptors to anyNGS-generated
proﬁle.
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ChIP-seq proﬁle’s robustness dispersion provides quality
descriptors
This QC system evaluates the robustness of RCI disper-
sion for any given ChIP-seq and enrichment-related NGS
proﬁles by comparing distinct randomly sampled popula-
tions derived from the primary data set (Figure 1B).
Speciﬁcally, TMRs are ﬁrst resampled at 90, 70 and
50% (referred to as s90, s70 and s50, respectively) of the
original data set. The genome-wide read-count distribu-
tion within 500 bp bins is then evaluated for the sampled
subsets and compared with that observed for the original
proﬁle (s100) (for the effect of bin size on measuring
proﬁle robustness see Supplementary Figure S1). Under
the assumption of a proportional RCI decrease on read
subsampling (saturation concept), the bin RCI divergence
from expectation is calculated (dRCI or local divergence;
deﬁned as the difference between the theoretically
expected RCI and that observed after resampling).
Furthermore, a global quantitative assessment of the
changes in bin RCI dispersion is given by the evaluation
of the total bins presenting a deﬁned RCI dispersion. This
global indicator, deﬁned as density Quality indicator
(denQCi), evaluated in conditions where only a half of
the initial sequenced reads are available (s50), is systemat-
ically used in this study to illustrate the degree of robust-
ness of the evaluated proﬁle to the reads-subsampling
treatment (i.e. ds50 5% makes reference to the fraction
of bins with dRCI 5% when half of the TMRs are used
for proﬁle reconstruction).
Furthermore, the changes in robustness on successive
read subsampling has been evaluated by comparing the
denQCi obtained for the subset closest to the original
proﬁle (s90) relative to that assessed from half of all
sequenced reads (s50). This second global indicator has
been deﬁned as the ‘similarity QC indicator’ (simQCi)
because it reveals the similarity between the robustnesses
assessed at s90 and s50. Overall, the higher the denQCi and
the lower the simQCi, the more ‘robust’ is the evaluated
proﬁle.
Figure 1. Assessing quality descriptors for ChIP-seq proﬁles. (A) Based on the rationale that a robust proﬁle displays a proportional decrease of its
RCIs along the genome when a randomly sampled population of its TMRs is used for proﬁle reconstruction, the present quality assessment method
quantiﬁes the deviation from the expected RCI decrease within deﬁned thresholds. (B) TMRs are randomly sampled into three distinct populations
(90, 70 and 50%), which are used for proﬁle reconstruction by computing the RCIs in 500-bp bins. The RCI divergence from expectation (dRCI) is
measured relative to the original proﬁle (s100). This information generates local QCis and is displayed together with the original RCI proﬁle to
identify robust chromatin regions (dRCI heat-map below the bottom proﬁle). In addition, two global QCis are calculated, comprising the density
QCi [denQCi, deﬁned as the fraction of bins displaying <5% dRCI after 50% TMRs sampling (‘ds50/5’)] and the similarity QCi (simQCi), deﬁned as
ratio of denQCi after 90% sampling over that after 50% sampling (‘ds90/s50/5’). (C) Genome-browser screenshots of three different H3K4me3 ChIP-
seq proﬁles. In addition, the RCI dispersion per 500-bp bins (local QCi) is illustrated as color-coded heat-map below the corresponding ChIP-seq
proﬁles. Note that while all three proﬁles present 19 million TMRs, they differ signiﬁcantly in their global RCI amplitudes. Furthermore, their
corresponding global QCis assessed from 5 random sampling assays are displayed (average±standard deviation).
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ChIP-seq proﬁles established from similar TMRs can
lead to variable quality patterns as revealed by visual
inspection of three ChIP-seq proﬁles of the tri-methylation
of lysine 4 of histone 3 (H3K4me3) generated with
antibodies obtained from the same supplier and with
similar (19 millions) TMR levels (Figure 1C). Yet, they
present major differences of global RCIs and background
levels (note the different scales). Indeed, the computing of
the QCis provides quantitative descriptors (denQCi,
ds50 5% and simQCi, ds90/s50 5%) for the relative
quality of the three proﬁles, which fully comply with the
visual quality assessment, thus illustrating the usefulness
of this approach in providing quantitative QC values
for comparing different ChIP-seq data sets. Note that
multiple random TMR samplings performed for each of
the illustrated proﬁles revealed a coefﬁcient of variation of
<2% for the computed QCis. This demonstrates a high
stability of the measurement of global QCis even when
derived from a single random drawing (Figure 1C and
Supplementary Figure S2).
Sequencing-depth inﬂuences the quality of ChIP-seq
proﬁles
ChIP-seq and related assays are in most cases based on
reads obtained from a single ﬂow cell channel.
Importantly, read densities of ﬂow cells have largely
increased over the past few years, ranging from <40
million for the ﬁrst Genome Analyzer from Illumina
(GA1) to >3 billion reads (300Gb) for the Hiseq2000
platform. Consequently, the TMRs used for proﬁle recon-
struction can vary dramatically, inducing questions con-
cerning the comparability of proﬁles that were constructed
with different amounts of TMRs.
To evaluate the direct inﬂuence of sequencing depth on
NGS-proﬁling robustness, we performed an analysis of
biological replicates for ERa binding in H3396 breast
cancer cells (3), which was performed by using one
channel of the GA1, GA2X or HiSeq2000 platforms.
We also included a comparison with half of a HiSeq
channel by using multiplex technology. As expected, the
sequencing depth provided by the different sequencing
platforms, correlates well with the overall RCIs
(Figure 2A). Importantly, TMR sampling analysis
revealed a 16.2-fold increase of denQCi and, thus, global
proﬁle ‘robustness’, with increased sequencing depth
(‘ds50 5%’ in Figure 2A).
As expected, the number of TMRs used for ERa proﬁle
construction strongly inﬂuenced the total number of pre-
dicted statistically signiﬁcant binding sites. In fact, with
>50 million reads for the Hiseq2000 proﬁle, 22 150 ERa
sites were predicted (FDR adjusted P-value threshold
104.5; for peak detection algorithm, see ‘Materials and
Methods’ section). In contrast, only 2038 sites were pre-
dicted from 5 million reads obtained with one GA1
channel (Figure 2B). Albeit the total number of predicted
peaks increased strongly with increasing sequencing
depths, the number of sites that complied with ds50 5%
shows a much slower increase and entered a plateau phase
above 24 million TMRs. This indicates that the ‘robust’
ERa binding sites approach saturation as deﬁned in
previous studies on sequencing depth and de novo discovery
of transcription factor binding sites (5,29,30).
As we have proﬁled ERa binding under identical treat-
ment conditions, it was reasonable to assume that the
sites identiﬁed at low sequencing depth constitute a
subpopulation of those identiﬁed in the high TMR
proﬁles. In fact, when comparing the ERa binding sites
predicted at highest sequencing depth with those derived
from the other proﬁles, not only the number but also the
robustness of peaks in the overlapping population
increased with increasing sequencing depth. From 1321
ERa sites in the overlap between GA1 and the full
channel HiSeq2000 proﬁle, >80% of them (1096 sites)
comply with ds50 5% (Figure 2C). Similarly, the
number of ERa binding sites overlapping with the GA2X
or half channel HiSeq2000 data sets increased strongly over
that obtained withGA1, as did the number of robust peaks.
The above comparison revealed also a signiﬁcant
number of nonoverlapping sites (Figure 2C). While it is
reasonable to assume that the outliers of the HiSeq2000
proﬁle (red) result mainly from the incomplete binding site
recovery from the other proﬁles, those outliers that are
seen in the low TMR proﬁles but not in the HiSeq2000
are more likely ‘false positives’. Indeed, the number of
such sites is variable and does not follow a common
trend as the increase of the overlap population with
increasing sequencing depth; in this respect, the GA2X
data set is suboptimal with 4- to 5-times more outliers
(green) than the GA1 (gray) and 1/2Hiseq (blue) ones.
Importantly, when considering only the robust peak popu-
lation, the GA2X outliers were signiﬁcantly reduced
to about the level seen with GA1 and 1/2Hiseq ones. In
addition, the nonoverlapping sites, including those of the
full channel HiSeq2000, showed consistently lower peak
intensities and weaker conﬁdence P-values relative to
overlapping population (Figure 2D).
Considering the full channel HiSeq data set as ‘gold
standard’, the number of recovered ‘true’ ERa binding
sites increased from <5% for the GA1 data set to
60% for the half channel HiSeq2000 proﬁle
(Figure 2E). Importantly, 80% ‘true positive’ binding
sites were recovered when only robust ERa sites are con-
sidered, indicating that the denQCi criterion identiﬁes the
highly reliable sites when comparing ChIP-seqs with
largely differing sequencing depths.
The QCis are universally applicable to all ChIP-seq and
enrichment-related NGS proﬁling assays
While in previous studies proﬁle saturation has been
deﬁned after peak calling (5,29,30), the present QC evalu-
ation system evaluates robustness directly from the raw
pattern of genome-aligned reads. Therefore, QCis can
be established for any type of enrichment-related NGS
proﬁles, including ChIP-seq, RNA-seq, GRO-seq and
others, making this methodology a universal tool for multi-
dimensional quality proﬁle comparison. Indeed, we have
computed QCis for several types of publicly available
NGS-generated proﬁles and observed a high variability
between the corresponding QCis even when data sets
with similar TMRs were compared (Figure 3A and
Supplementary Figure S3). RNA-seq, which does
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Figure 2. ERa binding sites detection assessed for different sequencing depths. (A) ERa RCI proﬁles obtained from different sequencing platforms
[i.e. Genome Analyser 1 (GA1); GA2X and Hiseq2000] are illustrated. Each of the displayed ChIP-seq proﬁles was obtained by sequencing a single
channel of the corresponding platform except for Hiseq2000, where half a channel or a full one was used. The corresponding mapped reads and their
associated denQCi (ds50 5%) are displayed. (B) Total ERa binding sites identiﬁed in ChIP-seq proﬁles generated at different sequencing depths
compared with those that complied with the ds50 5% criterion. ERa binding sites were predicted with MeDiChI (FDR adjusted P-values threshold
104.5; see methods for details). (C) Venn diagrams illustrating overlap and outlier populations for ERa binding sites retrieved from sequencing a full
HiSeq2000 channel compared with those identiﬁed at lower sequencing depths. This analysis was performed for total ERa sites (top panel) and those
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not involve manipulations like cross-linking and
immunoselection, generated the most robust proﬁles,
while a nonenriched input proﬁle (whole-cell extract,
WCE) constructed from 19 million TMRs displayed the
worst quality indicators. For nearly identical TMRs, the
ChIP-seq proﬁle of H4K20me1 revealed signiﬁcantly
improved QCis, as expected for the immunoselection of
speciﬁc chromatin regions. Importantly, other histone
modiﬁcation proﬁles constructed from similar or even
lower TMRs displayed better QCis than either
Figure 3. QCis for several types of ChIP-seq and enrichment-related NGS proﬁles. (A) Scatterplots illustrating the RCI dispersion (dRCI%) after
sampling for different types of NGS proﬁles (overlays of s90, black; s70, blue; s50, red). TMR, density (denQCi, ds50 5%) and similarity (simQCi,
ds90/s50 5%) QCis are indicated. Note that the input proﬁle has the lowest denQCi and highest simQCi (WCE; top left), whereas the highest
denQCi and lowest simQCi were measured for an RNA-seq proﬁle (bottom right). (B) RCI dispersion per 500-bp bins is illustrated as color-coded
heat-map (indicated at left) below the corresponding ChIP-seq proﬁles. (C) Density and similarity QCis for different proﬁles of the indicated histone
modiﬁcations are compared with input WCE proﬁles. Note the different characteristics of the target proﬁles on increasing TMRs, which reveals that
for H4K20me1 and H3K36me3 proﬁles presenting TMRs <15 million present QCis similar to the input. (D) Density and similarity QCis are
displayed at stringent (ds50 2.5%), intermediate (ds50 5%) and relaxed (ds50 10%) dispersion intervals.
Figure 2. Continued
complying with ds50 5% (bottom panels). (D) Boxplots displaying peak intensity and FDR adjusted P-value associated to overlap and outlier
populations displayed in (C). Note that the ERa sites in the overlaps show systematically higher intensities and conﬁdence than the outliers and that
this difference is decreased for the ds50 5% populations. (E) Considering the sites identiﬁed with the full HiSeq2000 channel as ‘true’ sites, the
fraction of true sites recovered in the compared proﬁles (top panel), as well as the false calls, estimated from the outlier population (bottom panel)
are illustrated. Note the increase of true sites and a concomitant decrease of false calls in the population that complies with ds50 5%.
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H4K20me1 or WCE, thereby revealing that the robustness
of a proﬁle depends not only on the sample preparation
and sequencing depth but also on the nature of the
immunoprecipitated target. Note that H4K20me1 and
H3K36me3 generate rather broad enrichment proﬁles
revealing a spread of the mark over a large chromatin
region, while those established for H3K27ac or
H3K4me3 exhibit more discrete patterns of locally
conﬁned marks (Figure 3B). Our observation that the
500-bp RCI dispersion is generally higher in the
H4K20me1 or H3K36me3 proﬁles compared with those
of H3K27ac or H3K4me3 (see heat-map dRCI dispersion
in Figure 3B) is likely to originate from the combination of
several effects, including (i) the spread, local density and
accessibility of the marks and (ii) the quality (i.e. afﬁnity
and selectivity) of the antibodies.
In addition to revealing quality differences between data
sets for different targets at similar TMRs, the QCi com-
putation also provides important quality information
about data sets for the same target at different sequencing
depths. Indeed, comparing the QCis for several
H4K20me1 data sets generated from largely different
TMRs reveals that below 15 million TMRs the QCis
become indistinguishable from the WCE proﬁles,
strongly arguing that signiﬁcantly higher sequencing
depths are essential to establish accurate proﬁles for
such targets (Figure 3C). In contrast, H3K4me3 or
H3K27ac ChIP-seq proﬁles have good QCis even for
TMRs below 15 million reads.
That we observe major QCi differences between the
various data sets reported for similar TMRs indicates
that—in addition to the inherent pattern of the evaluated
target—other factors, involving most likely all the experi-
mental steps that generate the ultimate DNA library for
sequencing, inﬂuence the quality of the proﬁle (Figure 3C
and Supplementary Figure S3).
Whereas most of the above described QCis have been
established for a dispersion interval of 5% (ds50 5%),
different dispersion thresholds (e.g. ds50 2.5% or
ds50 10%) may reveal additional characteristics of the
studied proﬁles. Indeed Figure 3D illustrates that the QCis
determined for different dispersion intervals do not neces-
sarily show a linear relationship. This information has
been used as an additional source for quality evaluation
(see below QC-STAMP) and represents a potential
method for deﬁning common QCi conditions in the case
of multi-proﬁle comparisons by allowing variable robust-
ness dispersion cutoffs (Supplementary File S1).
NGS-QCi Generator: a stand-alone in silico platform
for computing QCis
The above methodology infers local and global quality
indicators for any available NSG-generated proﬁle follow-
ing a stand-alone approach, as it does not require
additional wet-lab efforts. It has been implemented in
the NGS-QCi Generator, a computational tool that is
accessible at a customized cloud of the web-based
platform Galaxy (31–33) (Supplementary File S1). The
NGS-QCi Generator provides a comprehensive report
summarizing the global QCis (Supplementary Figure S4)
and provides access to the computed RCI dispersion per
500-bp bins (wiggle or BED format) deﬁned as local QCis,
which can be used to identify the robustness of speciﬁc
regions of interest (Figure 3B and Supplementary
Figure S5). Using the NGS-QCi Generator we have
created a QCis database, which comprises at present the
QC analysis of >5600 NGS data sets, including ChIP-seq
proﬁles of histone modiﬁcations and variants, transcrip-
tion factors, as well as GRO-seq and RNA-seq proﬁles
(Figure 4A). This QCi database will be expanded to
cover virtually all of the publicly available NGS proﬁles.
To facilitate and simplify the recognition of QCi diver-
gence between proﬁles we have deﬁned QC-STAMP, a
global descriptor that combines the information provided
by denQCi and simQCi. The QC-STAMP corresponds to a
three-letter code composed of A, B, C and D that is derived
from the position of a given proﬁle QCi within the distri-
bution of compiled QCis in the database. The ﬁrst letter
reveals this position for a dRCI dispersion threshold of
2.5%, the second and third letter for 5% and 10% dRCI,
respectively. A to D grading was done to specify the fol-
lowing intervals: D, lower quartile (<25%); C, interquar-
tile (25–50%); B, interquartile (50–75%); A, upper quartile
(>75%) (Figure 4B). As an example, the H3K4me3 proﬁle
derived from 10 007 440 TMRs [arrow (3) in Figure 4A]
classiﬁed as ‘triple A’ proﬁle, while nonenriched WCE
proﬁles were, as expected, of the lowest possible quality,
‘triple D’ (Figure 4C). Similarly expected was the high QC
performance of RNA-seq, which does not involve the
complex experimentation and immunoprecipitation pro-
cedures as ChIP-seq, and consequently received ‘triple A’
rating [arrow (1) in Figure 4A]. Note that these ratings are
meant to provide a simpliﬁed view of the evaluated proﬁle’s
robustness but not to replace the QCis, which provide more
speciﬁc information.
As the quality of a ChIP-seq proﬁle is the direct conse-
quence of a rather large number of factors (e.g. cross-
linking efﬁciency, chromatin shearing, antibody afﬁnity
and selectivity, variability between experiments, experi-
menters and platforms), the QCis cannot per se identify
the source for the bad quality of a given proﬁle. However,
it does allow identifying data sets of divergent quality,
which cannot be compared with each other, even though
they might have been generated under similar conditions.
Importantly, in contrast to current practice, the sequencing
depth applied for generating NGS proﬁles is a tunable par-
ameter to generate proﬁles of similar quality. As illustrated
in Figures 3 and 5 for similar TMR levels, H4K20me1 or
H3K36me3 proﬁles display in general poorer quality than
those of H3K27ac or H3K4me3. However, increasing the
sequencing depth will improve their quality descriptors to
attain comparable levels, such that, for example, only
‘triple A’ data sets can be compared (Figure 5). In this
respect, we believe that the QCi database will become an
important reference to perform a priori predictions of the
minimal sequencing depth required for a given target to
reach a predeﬁned quality.
The NGS-QCis in the context of previously described
working standards and guidelines for ChIP-seq assays
Multidimensional comparative analyses of ChIP-seq
proﬁles require prior quality assessment. Currently, this
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is done by visual inspection of proﬁles in a genome
browser (for instance by evaluating the pattern in
regions previously described as containing a chromatin
enrichment) and complemented peak caller predictions
based on (some) user-deﬁned parameters.
In addition to visual inspection, analytical methods have
been developed with the aim of providing quantitative
quality assessments of NGS-generated proﬁles [for a
recent summary of the methodologies used by the
ENCODE consortium see (22)]. Methods like FRiP (23)
or IDR (24) require prior use of peak calling algorithms for
evaluation and are therefore dependent on peak-calling
performance of a given tool with the user-deﬁned param-
eters. Consequently, they cannot be easily used for multi-
proﬁle comparisons when different peak callers are
required. This is for example the case when transcription
factor proﬁles are compared with epigenetic proﬁles that
display broad RCI patterns. Note that the IDR approach
can only be used when replicate proﬁles are available,
which is strongly suggested but not a routine procedure
(see GEO entries). Furthermore, the criteria used for repro-
ducibility by the IDR analysis can be misleading in cases
where compared proﬁles present broad enrichment
patterns (Supplementary Figure S6; see also below).
Two other methods; signal distribution skewness (34)
and strand cross-correlation analysis (SCC) (22) operate
in a peak caller-independent manner. Signal distribution
skewness evaluates the asymmetry of genome-wide tag-
count distribution, while SCC measures the quality of
evaluated ChIP-seq proﬁles from the sequence tag
density on forward and reverse strand reads at target
sites. SCC is thus applicable mainly, if not exclusively,
Figure 4. A universal NGS-QCi database for comparative analysis. (A) Cloud of NGS-QCis for multiple proﬁles present in the NGS-QCi database
(http://igbmc.fr/Gronemeyer_NGS_QC). Density (left) and similarity (right) QCis are displayed relative to the TMRs; color codes are indicated at
the right. QCis of input (WCE) proﬁles are displayed as black circles; the dashed line is the corresponding ﬁtted curve. Arrows indicate the location
of the data sets speciﬁed in (C). (B) QCis of the evaluated NGS proﬁles displayed in (A) are expressed in a single term, QC-STAMP, and represented
as boxplots for different RCI dispersion intervals (2.5, 5 and 10%). Discrete quality grades ‘A’ to ‘D’ were associated with different quantiles
(QC-STAMP dist> 75%; >75% QC-STAMP dist> 50%; >50% QC-STAMP dist> 25%; QC-STAMP dist< 25% associated to A, B, C and D
qualitative indicators, respectively). (C) Examples of NGS proﬁles associated to different QC-STAMPs.
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Figure 6. Comparison of QCi-STAMP performance with other analytical methodologies. (A) A set of four biological duplicates was selected from
publicly available CTCF ChIP-seq proﬁles (pairs are enhanced by color code) and their corresponding QCi-STAMP descriptors were inferred (‘A’ for
highest and ‘D’ for lowest quality). (B) The skewness of the read-count signal distribution of the biological replicates compared with the predicted
QCi-STAMP (dRCI 5%). Note that the QCi-STAMP descriptors discriminate between data set (3) and (4), while their skewness evaluation does
not. (C) Signiﬁcant binding sites were predicted by MACS (default P-value threshold: 1 105) and classiﬁed based on their overlap between CTCF
replicates (common and unique sites). Common sites were assessed by accepting up to 40-nt distance between MACS-predicted summits. (D) ‘IDR’
among CTCF replicates assessed by sorting signiﬁcant binding sites according to the corresponding P-value. Note that in agreement with the QCi-
STAMP descriptors, but differing with the skewness analysis (see panel C), data sets (3) and (4) present the worst IDR, while data sets (5) and (6)
present the best IDR pattern.
Figure 5. Meta-analysis illustrating the inﬂuence of the sequencing depth on the density and similarity QCis. Meta-analysis performed by compiling
several proﬁles and subsequently sampled at deﬁned TMRs ranging from 20 to 180 million. For each resampled subset the corresponding QCis were
computed and displayed in spider-web charts, in which denQCi and simQCi are displayed for different dRCI thresholds (color-coded as indicated
at the top left). QC-STAMPs have been associated to the evaluated proﬁles as illustrated. Note that for H4K20me1 sequencing depths of up to
60 million reads are required to obtain a ‘triple A’ grade, while H3K27ac and H3K4me3 receive this grade with 20 million TMRs.
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to ‘sharp’ patterns like those observed for transcription
factor ChIP-seq data sets. It is rather evident that SCC
cannot be used for quality assessment of broad patterns,
as signiﬁcantly enriched reads of such proﬁles cover large
areas. Thus, from the conceptual point of view in addition
to the present QCi system, signal distribution skewness
appears to constitute the only other universal quality
measurement method. To compare signal distribution
skewness and our NGS-QC we have evaluated the
degree of skewness in four publicly available CTCF
ChIP-seq data sets (each of them represented by two
biological replicates) and compared it with QCi-STAMP
(Figure 6A and B). Both methods provide similar quality
predictions, with the important exception that the
difference in quality of one pair of the evaluated
replicates (GSM646372 and GSM646373 data sets) was
predicted by the QCi-STAMP but not by the skewness
analysis (Figure 6B). To understand the origin of this
discrepancy, we assessed the number of common and
unique sites for each pair of replicate data sets [peak
caller MACS (27); default P-value threshold conditions:
1 105), followed by IDR analysis for the predicted
binding sites (Figure 6C and D, respectively).
Interestingly, this complementary analysis revealed a
lower number of signiﬁcant common sites for replicate
GSM646372 (‘triple C’) and GSM646373 (‘triple B’)
than for the other replicate data sets. This IDR-deﬁned
differential quality of the two pairs of replicates was
equally well detected by the QCi-STAMP (but not the
skewness) approach. Overall, these comparisons show
that QCi-STAMP provides a more versatile and reliable
quality discrimination of NGS-generated proﬁle than the
skewness approach. Moreover, in contrast to IDR, QCi-
STAMP reveals which of the replicates should be repeated
to increase the overall quality without the necessity of
using peak caller approaches.
An additional limitation of the IDR analysis, namely
the dependence on peak caller performance, becomes
apparent from analysing CTCF (Figure 6; sharp peaks)
and H3K4me3 data sets (Supplementary Figure S6;
broad peaks). While IDR analysis of CTCF can be done
with 40 nt summit distance overlaps (i.e. the maximal
distance between predicted summits to consider two
binding events as reproduced), such conditions are nonin-
formative for the H3K4me3 data set. To overcome this
limitation, larger summit distance thresholds (e.g. 500 nt)
have to be used to get informative results (Supplementary
Figure S6). It is thus unlikely that comparisons between
ChIP-seq proﬁles presenting different enrichment patterns
can be done with IDR. In contrast, the QCi-STAMP
reliably predicts the different qualities for the ‘triple A’
and ‘triple B’ pair of replicates and the common quality
for the two ‘triple B’ replicates in the case of the evaluated
H3K4me3 data sets (Supplementary Figure S6A), as
illustrated for the CTCF proﬁles (Figure 6A).
DISCUSSION
The assessment of the quality of ChIP-seq data sets has
been mostly performed by visual inspection in a genome
browser and/or by the capacity of peak/island/pattern
caller algorithms to predict locally enriched sequence
counts. In both cases, it is a rather subjective analysis
relying on user-deﬁned criteria, such as the choice of ‘rep-
resentative’ regions or thresholds for peak detection, and
the statistical models and/or parameters used for assess-
ment of enriched patterns. Only recently, methods are
being developed that aim at providing a quantitative
measure for the quality of ChIP-seq assays but so far
there is no tool that provides a universal quality assess-
ment for past and present NGS-generated proﬁles.
The present NGS-QC approach provides quantitative
QCis generated from the evaluation of a feature
common to all NGS-generated proﬁles, namely the
proﬁle construction from sequenced read overlaps.
Conceptually, the QC Generator interrogates the robust-
ness of such a proﬁle when fewer sequenced reads
are available, irrespective of the underlying experimen-
tal approach; simplistically this can be described as a
numerical analysis similar to the visual inspection of
Figure 2A, which displays RCIs at different TMRs but
for the entire genome-aligned proﬁle and not only for a
selected region.
This concept has an inherent universal dimension,
which is essential for comparative purposes and consider-
ing that the public GEO repository represents a powerful
source for performing in silico data set comparisons, we
have established a database of QCis for >5600 proﬁles.
Our ultimate goal is to cover all publicly available ChIP-
seq and enrichment-related NGS data sets to provide a
comprehensive QCi library to the scientiﬁc community.
Moreover, we invite all our colleagues to use the QC
Generator for evaluation of their own proﬁles and
suggest that all newly reported IP-based NGS proﬁles
(which show the largest variability) are provided with
the corresponding global QCis. We also invite the com-
munity to import all newly deﬁned QCis into the global
QCi database. Collectively, this database will be a highly
valuable source of information about the quality that can
be achieved, for example, for ChIP-seq of a certain target
with a given (batch of) antibodies.
We believe that the universality, together with its sim-
plicity and broad accessibility, makes the present system
an attractive tool for QC analysis of proﬁles before
engaging peak detection algorithms. Once a proﬁle has
been QCed, the QC descriptors provide objective numer-
ical criteria to any NGS-generated proﬁle that is provided
to the community. Thus, existing proﬁles can be compared
with others in multidimensional studies and meta-
analyses.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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